Zydus Lifesciences has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported 76.01% rise in its net profit at Rs 450.40 crore for Q3FY24 as compared to Rs 255.90 crore for the same quarter in the previous year. Total income of the company increased by 15.30% at Rs 2478.10 crore for Q3FY24 as compared Rs 2149.30 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported 26.76% rise in net profit at Rs 789.60 crore for the third quarter ended December 31, 2023 as compared to Rs 622.90 crore for the same quarter in the previous year. Total income of the company increased by 5.76% at Rs 4542.90 crore for Q3FY24 as compared Rs 4295.60 crore for corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.00 |
Dr. Reddys Lab | 6260.00 |
Cipla | 1419.55 |
Zydus Lifesciences | 988.00 |
Lupin | 1647.75 |
View more.. |